These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 311606)

  • 1. Novel beta-lactamase from Branhamella catarrhalis.
    Hoi-Dang AB; Brive-Le Bouguenec C; Barthelemy M; Labia R
    Ann Microbiol (Paris); 1978 Oct; 129 B(3):397-406. PubMed ID: 311606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.
    Stobberingh EE; van Eck HJ; Houben AW; van Boven CP
    Drugs; 1986; 31 Suppl 3():23-7. PubMed ID: 3488194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.
    Labia R; Barthelemy M; Le Bouguennec CB; Buu Hoi-Dang Van A
    Drugs; 1986; 31 Suppl 3():40-7. PubMed ID: 3488196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children.
    Ejlertsen T; Skov R
    APMIS; 1996; 104(7-8):557-62. PubMed ID: 8920809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
    Renkonen OV
    Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer of beta-lactamase production in Branhamella catarrhalis.
    Kamme C; Vang M; Ståhl S
    Scand J Infect Dis; 1983; 15(2):225-6. PubMed ID: 6603655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.
    Murray BE; Mederski-Samaroj B
    J Clin Invest; 1983 Sep; 72(3):1168-71. PubMed ID: 6411768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchopulmonary infection due to Branhamella catarrhalis.
    McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis.
    Malmvall BE; Brorsson JE; Johnsson J
    J Antimicrob Chemother; 1977 Jul; 3(4):374-5. PubMed ID: 408320
    [No Abstract]   [Full Text] [Related]  

  • 10. Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.
    Nash DR; Wallace RJ; Steingrube VA; Shurin PA
    Drugs; 1986; 31 Suppl 3():48-54. PubMed ID: 3488197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.
    Doern GV; Siebers KG; Hallick LM; Morse SA
    Antimicrob Agents Chemother; 1980 Jan; 17(1):24-9. PubMed ID: 6766292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branhamella catarrhalis--an emerging human pathogen.
    Doern GV
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3):191-201. PubMed ID: 3514103
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-lactamase activity and resistance to ampicillin, carbenicillin, and cephaloridine of Klebsiella, Enterobacter, and Citrobacter.
    Slocombe B; Sutherland R
    Antimicrob Agents Chemother (Bethesda); 1969; 9():78-85. PubMed ID: 5202413
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of beta-lactamase inhibitors on Staphylococcus aureus susceptibility to penicillin G and penicillinase-resistant penicillins.
    Montanari MP; Varaldo PE
    J Chemother; 1989 Jul; 1(4 Suppl):344-5. PubMed ID: 16312431
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the induction of beta-lactamase synthesis in Pseudomonas aeruginosa strains on their resistance to penicillin].
    Braginskaia NS; Chaĭkovskaia SM
    Antibiotiki; 1975 Jan; 20(1):59-62. PubMed ID: 804846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.
    Calder MA; Croughan MJ; McLeod DT; Ahmad F
    Drugs; 1986; 31 Suppl 3():11-6. PubMed ID: 3488189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid-mediated beta-lactamase in Branhamella catarrhalis.
    Kamme C; Eliasson I; Knutson BK; Vang M
    Drugs; 1986; 31 Suppl 3():55-63. PubMed ID: 3488198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.
    Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL
    Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branhamella catarrhalis: antibiotic susceptibility and beta-lactamase production.
    Brorson JE; Martinell J; Wilske H
    J Antimicrob Chemother; 1981 Feb; 7(2):208-9. PubMed ID: 6971288
    [No Abstract]   [Full Text] [Related]  

  • 20. Branhamella catarrhalis: an unappreciated pulmonary pathogen.
    Roth RM; Gleckman RA; Hibert DM
    Am Fam Physician; 1984 Oct; 30(4):169-73. PubMed ID: 6333806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.